Filing Details

Accession Number:
0001181431-13-034558
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-12 19:30:33
Reporting Period:
2013-06-10
Filing Date:
2013-06-12
Accepted Time:
2013-06-12 19:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538685 John Pratt C/O Pacira Pharmaceuticals, Inc.
10450 Science Center Drive
San Diego CA 92121
General Manager, San Diego No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-10 5,398 $10.81 5,398 No 4 M Direct
Common Stock Disposition 2013-06-10 5,398 $30.00 0 No 4 S Direct
Common Stock Acquisiton 2013-06-11 12,945 $10.81 12,945 No 4 M Direct
Common Stock Disposition 2013-06-11 12,945 $30.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-06-10 5,398 $0.00 5,398 $10.81
Common Stock Employee Stock Option (right to buy) Disposition 2013-06-11 12,945 $0.00 12,945 $10.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
144,602 2022-06-04 No 4 M Direct
131,657 2022-06-04 No 4 M Direct
Footnotes
  1. The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vests and becomes exercisable as to the remaining shares in successive equal monthly installments for the subsequent 36 months.